Vaccine For Omicron Variant: Vaccine companies in the world have taken the lead against the new variant of the coronavirus, Omicron. Vaccine manufacturers have started working on a new vaccine, with the World Health Organization classifying this variant as a 'Variant of Concern'. This has given a new hope to overcome this crisis. Let us know what the vaccine manufacturing companies in the world have said about vaccine development.
Britain claims vaccine in the final stage of the trial
During this crisis, relief news has come out from Britain. Britain has claimed that a British vaccine giving strong protection against the super mutant corona strain is already in the final stages of its testing. Regarding the new version of Corona, various vaccine manufacturers have shared their feedback on the development of the vaccine. These include Pfizer/BioNTech, Moderna, AstraZeneca, Johnson & Johnson, and Novavax. These vaccine manufacturing companies have told what strategy they are adopting to compete with this variant.
Pfizer indicated new vaccine will come in early 2022
1- Pfizer, which was among the first American pharmaceutical companies to make the corona vaccine in the world, has said that it will soon make a new vaccine against the new variant. Modern Inc.'s chief medical officer Paul Burton said the new vaccine against this variant will be available in large quantities by early 2022.
2- Earlier, the Pfizer company had claimed that the third dose of the vaccine would provide better protection against the beta variant of the corona. Pfizer and BioNTech believe that the third dose of the BNT162b2 vaccine has the potential to preserve the highest level of protective efficacy against all currently known variants, including Delta. The company says that a third dose of the vaccine may be needed to defeat Corona.
3- BioNTech said in a statement that this variant is spreading globally. The company said that our experts have immediately started an investigation on the variant of B.1.1. We expect more data from lab tests in two weeks, the company said. These data will provide more information about whether B.1.1.529 may be an escape variant, which may require adjustment of our vaccine.
4- British pharmaceutical company AstraZeneca said that they are looking for B.1.1.529 to understand any new variants and their effects on the vaccine. Test results on the formula developed by the Oxford-AstraZeneca vaccine team are due in the next few days. If this formula is found to be effective against the new variant, it could be ready for use in a few weeks. This news has been given by immunologist Professor Sir John Bell, a member of the Government's Vaccine Task Force.
5- He said that at present it is too late to prevent the new variant from entering our borders from Southern Africa. John Bell says that it may be necessary to use modified forms of the vaccine if the vaccines currently being used prove to be ineffective. However, the good thing is that Britain was prepared for this amendment to a large extent. The credit goes to the members of the Oxford AstraZeneca team.
6- Significantly, the corona vaccine has been made jointly by Oxford University and British pharmaceutical company AstraZeneca. So far it has got approval in more than 50 countries. It has proved to be safe and effective in research conducted in Britain, Brazil, and South Africa. There has been some controversy regarding the data related to the vaccine. Britain first approved this vaccine. In the initial results, up to 70 percent was considered effective and this was the basis of approval.
WHO categorized as 'Variants of Concern'
Significantly, the World Health Organization had said that this new variant could be more dangerous than Delta. Because of its infectivity, the World Health Organization has placed this variant in the category of 'Variant of Concern'. This means that it is included in the five dangerous variants, which have caused havoc in the world. But vaccine manufacturing companies have tightened their gears to compete with it.
Dangerous virus in the category of a variant of concern
During the spread of the coronavirus, the World Health Organization has so far classified five dangerous variants as 'Variants of Concern'. Variants of concern are those variants, which spread rapidly. Shows severe symptoms. The effect of the vaccine on them is neutralized or the effect of the vaccine is reduced.
1- Alpha variant: The effect of this variant of the coronavirus was in Britain. In September 2020, this virus caused great destruction in Britain. Due to this thousands of lives were lost. A strict lockdown was imposed in the country to prevent the spread of the virus.
2- Beta Variant: In South Africa, the beta variant took a dangerous form. In May 2020, this virus caused huge destruction in South Africa and its surrounding countries.
3- Gamma variant: In November 2020, Brazil and its surrounding areas were in the grip of this virus. This variant caught millions of people. Brazil was among the countries where Corona had the most impact.
Pakistan: Pakistan's special representative for Afghanistan resigns, citing personal reasons
Pakistan's Special Representative for Afghanistan Mohammad Sadiq on Wednesday resigned from his p
On Wednesday, Delhi Police registered a case related to the lapse in security of Parliament under
Recently Prabhas's film 'Kalki 2898 AD' has been released. This film is getting a positive respon
Terrorists have targeted schools in Afghanistan. Three blasts took place in schools in Kabul on T
The 29th edition of the Kolkata International Film Festival (KIFF) began with grandeur at the Net
The Delhi government, which came to power by promising to give 200 units of free electricity to t
Amidst the Lok Sabha elections, the BJP is continuously accusing Congress that in Congress-r
The Women's Football World Cup is being hosted by Australia and New Zealand. Before the opening m
Delhi Chief Minister Arvind Kejriwal's plea to get his sugar level checked regularly and consult
RBI: RBI's MPC meeting from today, this will be a big decision to deal with inflation
The meeting of the Monetary Policy Committee of the Reserve Bank of India will begin today. The c
